Researchers have discovered a possible target for cancer immunotherapy. The research, directed by Professor Massimiliano Mazzone, discovered that the CDA gene is one of the most elevated metabolic genes in immunotherapy-resistant cancer. Inhibiting this gene through pharmacological or geneti
Immune Checkpoint Blockade, or ICB therapy, has become the gold standard for treating lung cancer because of its frequently successful results. High levels of the PD-L1 protein have served as the main indicator of a favourable response to treatment up until now
Houston [US], June 4 (ANI): Researchers have developed an ultrasound-guided cancer immunotherapy platform that promotes systemic antitumor immunity and increases immune checkpoint blockade therapeutic efficacy, according to the University of Texas MD Anderson Cancer Center.
Houston [US], May 30 (ANI): According to the University of Texas MD Anderson Cancer Center, researchers have developed an ultrasound-guided cancer immunotherapy platform that promotes systemic antitumor immunity and increases immune checkpoint blockade therapeutic efficacy.
Washington D.C. [USA], Feb 18 (ANI): Researchers have now discovered that a combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair (DDR) achieved significant tumour regression in mouse models of small cell lung cancer (SCLC).